View in EDS HTML Full Text PDF Full Text

Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases.

Saved in:
Bibliographic Details
Title: Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases.
Authors: Hamilton, Jennifer D.1 (AUTHOR) jennifer.hamilton@regeneron.com, Harel, Sivan1 (AUTHOR), Swanson, Brian N.2 (AUTHOR), Brian, William2 (AUTHOR), Chen, Zhen1 (AUTHOR), Rice, Megan S.3 (AUTHOR), Amin, Nikhil1 (AUTHOR), Ardeleanu, Marius1 (AUTHOR), Radin, Allen1 (AUTHOR), Shumel, Brad1 (AUTHOR), Ruddy, Marcella1 (AUTHOR), Patel, Naimish2 (AUTHOR), Pirozzi, Gianluca2 (AUTHOR), Mannent, Leda4 (AUTHOR), Graham, Neil M. H.1 (AUTHOR)
Source: Clinical & Experimental Allergy. Jul2021, Vol. 51 Issue 7, p915-931. 17p. 2 Diagrams, 2 Charts, 5 Graphs.
Database: Environment Complete
Full text is not displayed to guests.
Description
ISSN:09547894
DOI:10.1111/cea.13954